These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27629747)

  • 1. Clinical Aspects of the Use of Botulinum Toxin Type A in the Treatment of Dysfunction of the Masticatory System.
    Bogucki ZA; Kownacka M
    Adv Clin Exp Med; 2016; 25(3):569-73. PubMed ID: 27629747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent TMJ Dislocation Managed with Botulinum Toxin Type A Injections in a Pediatric Patient.
    Stark TR; Perez CV; Okeson JP
    Pediatr Dent; 2015; 37(1):65-9. PubMed ID: 25685976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
    Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder.
    Patel AA; Lerner MZ; Blitzer A
    Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):328-333. PubMed ID: 28290229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Botulinum toxin type A: an arsenal in dentistry.
    Rao LB; Sangur R; Pradeep S
    Indian J Dent Res; 2011; 22(3):440-5. PubMed ID: 22048586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.
    Li K; Tan K; Yacovelli A; Bi WG
    J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations.
    Freund BJ; Schwartz M
    Br J Oral Maxillofac Surg; 2003 Oct; 41(5):351-2. PubMed ID: 14581034
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of temporomandibular disorders with botulinum toxin.
    Schwartz M; Freund B
    Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of articular disc loading in the temporomandibular joints after prosthetic and pharmacological treatment in model studies.
    Pihut ME; Margielewicz J; Kijak E; Wiśniewska G
    Adv Clin Exp Med; 2017; 26(3):455-460. PubMed ID: 28791820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
    Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
    Hosgor H; Coskunses FM; Altindis S
    J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the current uses of Botox for dentally-related procedures.
    Bhogal PS; Hutton A; Monaghan A
    Dent Update; 2006 Apr; 33(3):165-8. PubMed ID: 16700273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of occlusal forces in the therapy of functional disorders with the use of botulinum toxin type A.
    Pihut M; Wisniewska G; Majewski P; Gronkiewicz K; Majewski S
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 8():113-6. PubMed ID: 20400803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
    Song PC; Schwartz J; Blitzer A
    Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
    von Lindern JJ; Niederhagen B; Bergé S; Appel T
    J Oral Maxillofac Surg; 2003 Jul; 61(7):774-8. PubMed ID: 12856249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.